Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes.

[1]  M. Berger,et al.  Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  D. Bajorin,et al.  BAYOU: A phase II, randomized, multicenter, double-blind, study of durvalumab (D) in combination with olaparib (O) for the first-line treatment of platinum-ineligible patients with unresectable, stage IV urothelial carcinoma (UC). , 2022, Journal of Clinical Oncology.

[3]  T. Powles,et al.  A randomized, double blind, biomarker selected, phase II clinical trial of maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma (mUC): Final analysis of the ATLANTIS rucaparib arm. , 2022, Journal of Clinical Oncology.

[4]  N. Schultz,et al.  Therapeutic Implications of Germline Testing in Patients With Advanced Cancers , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  R. Nussbaum,et al.  Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome. , 2020, JAMA oncology.

[6]  E. V. Van Allen,et al.  Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma , 2019, Genetics in Medicine.

[7]  Kenneth Offit,et al.  Cancer Susceptibility Mutations in Patients With Urothelial Malignancies. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  L. Kiemeney,et al.  Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018. , 2018, European urology.

[9]  N. Malats,et al.  Bladder Cancer Genetic Susceptibility. A Systematic Review , 2018, Bladder cancer.

[10]  Steven J. M. Jones,et al.  Pathogenic Germline Variants in 10,389 Adult Cancers. , 2018, Cell.

[11]  Steven J. M. Jones,et al.  Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer , 2017, Cell.

[12]  P. Kantoff,et al.  Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing , 2017, JAMA.

[13]  G. Parmigiani,et al.  Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. , 2016, JAMA.

[14]  Donavan T. Cheng,et al.  Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA. , 2016, JAMA oncology.

[15]  M. Nilbert,et al.  Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations. , 2015, Urology.

[16]  L. Kiemeney,et al.  Epidemiology and risk factors of urothelial bladder cancer. , 2013, European urology.

[17]  A. Evans,et al.  Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. , 2013, European urology.

[18]  L. Kiemeney,et al.  Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers , 2010, Journal of Medical Genetics.

[19]  C. Engel,et al.  Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. , 2009, Gastroenterology.

[20]  M. Greene,et al.  Familial and genetic risk of transitional cell carcinoma of the urinary tract. , 2008, Urologic oncology.

[21]  John D Potter,et al.  Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. , 2008, JAMA.

[22]  N. Malats,et al.  Risk of Bladder Cancer Associated with Family History of Cancer: Do Low-Penetrance Polymorphisms Account for the Increase in Risk? , 2007, Cancer Epidemiology Biomarkers & Prevention.

[23]  M. Spitz,et al.  Bladder cancer risk as modified by family history and smoking , 2006, Cancer.

[24]  P. Hartge,et al.  Familial and environmental interactions in bladder cancer risk , 1985, International journal of cancer.

[25]  H. Lynch,et al.  Familial factors in bladder carcinoma. , 1979, The Journal of urology.

[26]  D. Lamm,et al.  Familial transitional cell carcinoma of the bladder. , 1975, The Journal of urology.

[27]  J. Fraumeni,et al.  Malignant Bladder Tumors in a Man and His Three Sons , 1967 .